Prophylaxis with enoxaparin and antithrombin III in drug-induced coagulation alterations in childhood leukemia: a retrospective experience of 20 years

Table 1 Patient characteristics

	ALL-BFM 2000	ALL-BFM 2009	ALL-BFM 2017	Total population
Number of patients	72	78	23	173
Sex
Female	35	30	9	74 (42.8%)
Male	37	48	14	99 (57.2%)
Age groups
< 10 years of age	52	65	21	138
> 10 years of age	20	13	2	35
Age at diagnosis [years ± standard deviation]	7.28 ± 4.64	6.28 ± 4.69	6.05 ± 3.01	6.66 ± 4.49

ISSN: 1477-9560